Growth Metrics

Tandem Diabetes Care (TNDM) Net Cash Flow Growth (1y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 Tandem Diabetes Care 1.31 Bn 739.55 Mn 136.79 Mn 751.43%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 751.43%
Dec 31, 2025 -114.33%
Sep 30, 2025 1,051.86%
Jun 30, 2025 175.49%
Mar 31, 2025 -2,680.52%
Dec 31, 2024 185.11%
Sep 30, 2024 104.69%
Jun 30, 2024 -455.61%
Mar 31, 2024 101.18%
Dec 31, 2023 -144.41%
Sep 30, 2023 -659.42%
Jun 30, 2023 -84.41%
Mar 31, 2023 -300.90%
Dec 31, 2022 215.50%
Sep 30, 2022 -34.70%
Jun 30, 2022 195.80%
Mar 31, 2022 -14.02%
Dec 31, 2021 -17.37%
Sep 30, 2021 114.78%
Jun 30, 2021 -115.05%
Mar 31, 2021 10.09%
Dec 31, 2020 -809.38%
Sep 30, 2020 -1,284.09%
Jun 30, 2020 6,526.09%
Mar 31, 2020 1,817.20%
Dec 31, 2019 -47.78%
Sep 30, 2019 127.93%
Jun 30, 2019 80.89%
Mar 31, 2019 -102.83%
Dec 31, 2018 486.00%
Sep 30, 2018 -84.79%
Jun 30, 2018 7.30%
Mar 31, 2018 1,237.06%
Dec 31, 2017 -93.93%
Sep 30, 2017 -24.22%
Jun 30, 2017 -25.32%
Mar 31, 2017 247.54%
Dec 31, 2016 22,939.32%
Sep 30, 2016 -352.65%
Jun 30, 2016 37.70%
Mar 31, 2016 -107.90%
Dec 31, 2015 97.33%
Sep 30, 2015 90.52%
Jun 30, 2015 -31.78%
Mar 31, 2015 165.97%
Dec 31, 2014 -104.03%
Sep 30, 2014 -96.47%
Jun 30, 2014 -1,915.67%
Mar 31, 2014 -487.45%